Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-08

Posted on November 8, 2024August 1, 2026 By K-STOCK Editor No Comments on [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-08

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS is hosting multiple investor relations events via conference calls and in-person meetings to explain the background of its rights offering, review Q3 2024 earnings, and attend investor conferences.

📊 [Key Disclosure Details & Financial Summary]

  1. Schedule & Event Details:
  • Nov 08, 2024, 19:00: Online meeting explaining the rights offering (For Analysts)
  • Nov 11, 2024: Participation in KIS Global Investors Conference (Sponsored by Korea Investment & Securities)
  • Nov 14, 2024, 16:30: Online meeting for Q3 2024 Earnings Review (For Analysts)
  • Nov 21, 2024: Participation in Citi Korea Investors Conference (Sponsored by Citi)
  • H2 Regular NDR: Scheduled for November (Exact date TBD)
  1. Target Audience: Investors, Securities Analysts, etc.
  2. Purpose: Explanation of the background and purpose of ISU PETASYS’ rights offering and business outlook
  3. Sponsors: Korea Investment & Securities, Citi Securities
  4. Key Agenda:
  • Background and purpose of ISU PETASYS’ rights offering
  • Key business status and outlook
  • Q&A session
  1. IR Presentation Materials:
  • Posting Date: November 08, 2024
  • Official Website: http://www.petasys.com

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 IR Hosting for Rights Offering Explanation and Verification of Published Materials

The company is holding multiple investor relations meetings to present the background of its capital increase and review business performance. Reviewing the presentation contents and officially published materials is important to understand the rationale behind the rights offering and operational updates. Relevant materials can be tracked through the official IR documents posted on the company’s website on November 08, 2024.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official filing data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement (ALT-B4 Technology) / 2024-11-08
Next Post: [Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase / 2024-11-08

Related Posts

[Disclosure] SK Square (402340) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2025-06-30 Semiconductors
[Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26 Disclosures
[Disclosure] SK Square (402340) – Decision on Calling of General Shareholders’ Meeting / 2025-02-25 Semiconductors
[Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-02-08 Semiconductors
[Disclosure] Hanwha Systems (272210) Signs Supply Contract with Hyundai Rotem; Details Withheld Due to Business Confidentiality Disclosures
[Disclosure] SK Square (402340) – Decision on Closure of Shareholders’ Register (Record Date) for Cash/In-Kind Dividend / 2025-01-23 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme